Sales Growth YoY (Last 12 Months): Sanara MedTech Inc. (SMTI)

The development of Sanara MedTech Inc. (SMTI) depends on the adoption rate of regeneration tools in surgery and the penetration of hospital networks. Year-over-year sales dynamics over the last four quarters visualize this process, where 9.80 shows the current value of the metric. Revenue growth is driving the success of CellerateRX and the high-margin wound healing segment. Applied R&D efforts are focused on releasing new matrices and implementing telemedicine.
Sanara MedTech Inc. - analytical breakdowns and key metrics (SMTI)

To filter for high-quality assets, investors analyze revenue dynamics to distinguish short-term spikes from sustainable business expansion. This TTM annual sales growth measures the percentage change in sales over the last twelve months, confirming the expansion of Sanara MedTech Inc. (SMTI) within the wound healing segment and the effectiveness of margin protection through unique product properties in TTM annual sales growth.